Brain-Computer Interface

The Brain-Computer Interface (BCI) concept covers technologies that directly measure and modulate neural activity to enable communication and control between the brain and external devices. Core tracks include non‑invasive and implantable neural sensing hardware (EEG/ECoG/microelectrodes), neuromodulation systems, low‑latency signal processing and AI decoding software, neuroprosthetics and assistive communication, AR/VR and robotics integration, biocompatible materials and power, as well as safety, data, and clinical translation platforms.The sector's total market cap is 8297.12 billion USD, with a 24h change of -2.20%. Among 9 constituents, 2 are up (22.22%) and 7 are down (77.78%). The top gainer is Abbott Laboratories (ABT), with a 24h increase of +1.88%.BCI sector soft, with strength concentrated in top-tier names while smaller caps diverge. Near term, focus on core-theme leaders; medium term, align allocation with earnings cadence and rate trends.